Autopsy report · NCT03380936

Pilot Study of Treatment for Subclinical AMR (Antibody-mediated Rejection) in Kidney Transplant Recipients

“Slower than expected recruitment rate”

The sponsor’s own words in the registry.

Life of this trial

• Registered 3 months before it started.
• Ran for about 1 year 9 months before it stopped.
• 4 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Early Phase 1

Sponsor

University of Colorado, Denver

Sponsor type

University, hospital or other

Conditions

Kidney Transplant Rejection

Interventions

Tacrolimus Extended Release Oral Tablet [Envarsus]; Plasma Exchange and IVIG (Intravenous Immunoglobulin )

Participants

4

Sites

1

Countries

United States

Trials that died the same way

• Comparison of Embryo Transfer in Egg Donation Recipients With Transvaginal and Transabdominal Ultrasound
  “slow recruitment rate” (94% match in meaning)
• Serum-derived Bovine Immunoglobulin Effect on Mucositis
  “Recruitment slower than anticipated” (93% match in meaning)
• IU Health Krannert Personalized Medicine Study
  “Slower than anticipated recruitment” (92% match in meaning)
• The Effect of Episiotomy on Maternal and Fetal Outcomes (EPITRIAL)
  “Slower than expected recruitment rate, and larger than expected required sample.” (91% match in meaning)
• Pharmacokinetics of Ceftolozane/Tazobactam in Patients With Burns
  “Much slower recruitment than anticipated” (91% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.